DJIA 16,361.20 75.69 0.46%
NASDAQ 4,723.52 25.99 0.55%
S&P 500 1,955.39 14.88 0.77%
market minute promo

Array BioPharma (NASDAQ: ARRY)

5.73 0.05 (0.88%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARRY $5.73 0.88%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.71
Previous Close $5.68
Daily Range $5.64 - $5.91
52-Week Range $2.98 - $8.59
Market Cap $814.7M
P/E Ratio 81.14
Dividend (Yield) $0.00 (0.0%)
Volume 1,119,696
Average Daily Volume 1,807,412
Current FY EPS -$0.57

Sector

Healthcare

Industry

Drug Makers

Array BioPharma (ARRY) Description

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Website: http://www.arraybiopharma.com/

News & Commentary

3 Low-Price Biotech Stocks That Could Pop or Drop in 2016

Agenus Inc., Array BioPharma, and Idera Pharmaceuticals are expecting to release data from cancer drug trials in the coming year.

Premarket Biotech Digest: Major Mayo Research, Axovant Still Shortable, Mylan Perrigo Bid

InsiderInsights.com Daily Round Up 8/25/15: APD, AYR, KS, OPK

Key Insider Buying in Twitter, Level 3, Sears, MBIA and More

Insider Buys Round-up: Tenet Healthcare and Sprint Corp

InsiderInsights.com Daily Round Up 8/13/15: New Media Investment, Merrimack Pharmaceuticals, Martha

InsiderInsights.com Daily Round Up 8/13/15: New Media Investment, Merrimack Pharmaceuticals, Martha Stewart Living Omnimedia, Luby's

InsiderInsights.com Daily Round Up 8/10/15: MDLZ, TWTR, MBI, NEWM

Premarket Biotech Digest: My Investment Strategy, Geron Updates, Regeneron Earnings

'Mad Money' Lightning Round: Marriott International Is a Buy

Array BioPharma's (ARRY) CEO Ron Squarer on Q4 2015 Results - Earnings Call Transcript

See More ARRY News...

ARRY's Top Competitors

ARRY $5.73 (0.88%)
Current stock: ARRY
AMGN $152.32 (-1.08%)
Current stock: AMGN
GILD $106.12 (-0.79%)
Current stock: GILD
BIIB $300.86 (0.88%)
Current stock: BIIB